The digital dose inhalers global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Digital Dose Inhalers Market, 2024 The digital dose inhalers global market report 2024
Market Size –
The digital dose inhalers market size has grown exponentially in recent years. It will grow from $16.08 billion in 2023 to $19.60 billion in 2024 at a compound annual growth rate (CAGR) of 21.9%. The growth in the historic period can be attributed to rising respiratory diseases, increasing adoption of digital dose inhalers, increasing need to effectively monitor the date and time of dosing, increasing geriatric population, and increasing emphasis on customized healthcare.
The digital dose inhalers market size is expected to see exponential growth in the next few years. It will grow to $43.38 billion in 2028 at a compound annual growth rate (CAGR) of 22.0%. The growth in the forecast period can be attributed to the rise of telemedicine, increasing respiratory disease prevalence, increasing need for improved medication adherence and management, the rise of telemedicine, and rising consumer awareness. Major trends in the forecast period include integration of digital technologies, consumer awareness and education, cost-effectiveness, integration with IoT and AI, and telemedicine growth.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/digital-dose-inhalers-global-market-report
Scope Of Digital Dose Inhalers Market The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Digital Dose Inhalers Market Overview
Market Drivers –
The rising prevalence of chronic respiratory diseases is expected to propel the growth of the digital dose inhalers market moving forward. Chronic respiratory diseases are long-term conditions that affect the lungs and airways, leading to persistent breathing difficulties. The increasing incidence of chronic respiratory diseases can be linked to multiple factors, including heightened air pollution, an aging population, and increasing tobacco use. Digital dose inhalers are instrumental in enhancing medication adherence and monitoring for patients with conditions such as asthma and chronic obstructive pulmonary disease (COPD). For instance, in March 2022, the Centers for Disease Control and Prevention, a U.S. national public health agency, reported an increase in tuberculosis infections in 2021, with a total of 7,860 cases reported, rising from 7,173 cases in 2020. Thus, the growing prevalence of chronic respiratory diseases is driving the growth of the digital dose inhalers market.
Market Trends –
Major companies operating in the digital dose inhalers market are focused on developing innovative products, such as smart inhalers, to enhance patient outcomes and improve medication management. Smart inhalers are advanced devices with sensors and connectivity features that monitor drug usage, inhalation technique, and adherence while providing real-time feedback via mobile apps. For instance, in June 2024, Aseptika Ltd., a UK-based healthcare company, introduced the PUFFClicker3 universal smart inhaler dose tracker at the Med-Tech Innovation Expo. The PUFFClicker3 is the world’s first inhaler dose tracker compatible with both pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI), supporting 101 SNOMED-coded inhaler types. This innovation simplifies the transition between different inhaler types for patients and offers built-in graphical instructions for using each supported inhaler.
The digital dose inhalers market covered in this report is segmented –
1) By Product: Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)
2) By Type: Branded Medication, Generic Medication
3) By Indications: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications
4) By End User: Medical Device Industry, Hospital
Get an inside scoop of the digital dose inhalers market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18807&type=smp
Regional Insights –
North America was the largest region in the digital dose inhalers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital dose inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies in the market are AstraZeneca plc, Novartis AG, 3M Company, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., C.H. Boehringer Sohn AG & Co. KG, AptarGroup Inc., Cipla Limited, Chiesi Farmaceutici S.p.A., Lupin Limited, Glenmark Pharmaceuticals Limited, OPKO Health Inc., Nemera, Sensirion AG, Sunovion Pharmaceuticals Inc., MannKind Corporation, Adherium Limited, H&T Presspart, Monaghan Medical Corporation, BreatheSuite Inc.
Table of Contents
1. Executive Summary
2. Digital Dose Inhalers Market Report Structure
3. Digital Dose Inhalers Market Trends And Strategies
4. Digital Dose Inhalers Market – Macro Economic Scenario
5. Global Digital Dose Inhalers Market Size and Growth
.
.
.
32. Global Digital Dose Inhalers Market Competitive Benchmarking
33. Global Digital Dose Inhalers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Digital Dose Inhalers Market
35. Digital Dose Inhalers Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
